Enduring Material

Exploring Long-acting Injectable Buprenorphine
View Activity Info
Enter Basic User Info
Create Account
View Content
Take Post Test
Done
View Activity Info
Continue to Enduring Material
 
 
MyMichigan Health

4000 Wellness Drive
Midland, MI 48670
General Information
Thursday, May 8, 2025 - Sunday, May 7, 2028
60 minutes
MidMichigan Health
Virtual Conference Room
Michigan Medicine Opioid Overdose Prevention Education
MyMichigan Health
Objectives
  • Describe the different available long-acting injectable buprenorphine formulations and their dosing schedules.
  • Review current regulations related to prescribing and dispensing long-acting injectable buprenorphine.
  • Describe key considerations in determining patient eligibility for long-acting injectable buprenorphine
  • Compare the pros and cons of Sublocade and Brixadi in terms of patient selection
  • Explain the process of initiating and transitioning patients to long-acting injectable buprenorphine.
Presentations and Speakers
Exploring Long-acting Injectable Buprenorphine
  • Gregory Jones, MD
  • Thomas Michael Kates, DO
Available Credits/Points
  • MyMichigan Health designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • MyMichigan Health designates this enduring material for a maximum of 1 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statements
No planners or presenters have any relevant financial relationships with ACCME defined ineligible companies.
Speakers:
Gregory Jones, MD and Thomas Michael Kates, DO have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients to disclose.

Thomas Michael Kates, DO has indicated the presentation may include discussion of any off-label uses of a product. Explanation Given: Will mention some people using LAI's to discontinue Buprenorphine.

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of MyMichigan Health and Michigan OPEN. MyMichigan Health is accredited by the Michigan State Medical Society (MSMS) to provide continuing medical education for physicians. MyMichigan Health designates this live activity for a maximum of 1 AMA PRA Category Credit(s)TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Test Information
100 %
5/8/2025
Continue to Enduring Material